Sophia G de Vries1, Benjamin J Visser1, Ingeborg M Nagel2, Marga G A Goris3, Rudy A Hartskeerl3, Martin P Grobusch4. 1. Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1100 DE, room F4-220, Amsterdam, Netherlands. 2. Medical Library, Academic Medical Centre, University of Amsterdam, Netherlands. 3. WHO/FAO/OIE and National Leptospirosis Reference Centre, KIT Biomedical Research, Amsterdam, Netherlands. 4. Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1100 DE, room F4-220, Amsterdam, Netherlands. Electronic address: m.p.grobusch@amc.uva.nl.
Abstract
BACKGROUND: Leptospirosis is an emerging zoonotic infection worldwide, possibly due to climate change and demographic shifts. It is regarded as endemic in Sub-Saharan Africa; however, for most countries scarce epidemiological data, if any, exist. The primary objectives were to describe the prevalence of leptospirosis in countries in Sub-Saharan Africa, and to develop options for prevention and control in the future. METHODS: A systematic review was conducted to determine the prevalence of leptospirosis in Sub-Saharan Africa; the PRISMA guidelines were followed. Medline/PubMed, Embase, The Cochrane Library, Web of Science, BIOSIS Previews, the African Index Medicus, AJOL, and Google Scholar were searched. RESULTS: Information about the prevalence and incidence of leptospirosis in humans is available, but remains scarce for many countries. Data are unavailable or outdated for many countries, particularly those in Central Africa. Most data are available from animals, probably due to the economic losses caused by leptospirosis in livestock. In humans, leptospirosis is an important cause of febrile illness in Sub-Saharan Africa. It concerns numerous serogroups, harboured by many different animal carriers. DISCUSSION: A wide variety of data was identified. Prevalence rates vary throughout the continent and more research, especially in humans, is needed to reliably gauge the extent of the problem. Preventive measures need to be reconsidered to control outbreaks in the future.
BACKGROUND:Leptospirosis is an emerging zoonotic infection worldwide, possibly due to climate change and demographic shifts. It is regarded as endemic in Sub-Saharan Africa; however, for most countries scarce epidemiological data, if any, exist. The primary objectives were to describe the prevalence of leptospirosis in countries in Sub-Saharan Africa, and to develop options for prevention and control in the future. METHODS: A systematic review was conducted to determine the prevalence of leptospirosis in Sub-Saharan Africa; the PRISMA guidelines were followed. Medline/PubMed, Embase, The Cochrane Library, Web of Science, BIOSIS Previews, the African Index Medicus, AJOL, and Google Scholar were searched. RESULTS: Information about the prevalence and incidence of leptospirosis in humans is available, but remains scarce for many countries. Data are unavailable or outdated for many countries, particularly those in Central Africa. Most data are available from animals, probably due to the economic losses caused by leptospirosis in livestock. In humans, leptospirosis is an important cause of febrile illness in Sub-Saharan Africa. It concerns numerous serogroups, harboured by many different animal carriers. DISCUSSION: A wide variety of data was identified. Prevalence rates vary throughout the continent and more research, especially in humans, is needed to reliably gauge the extent of the problem. Preventive measures need to be reconsidered to control outbreaks in the future.
Authors: Sophia G de Vries; Benjamin J Visser; Rhett J Stoney; Jiri F P Wagenaar; Emmanuel Bottieau; Lin H Chen; Annelies Wilder-Smith; Mary Wilson; Christophe Rapp; Karin Leder; Eric Caumes; Eli Schwartz; Noreen A Hynes; Abraham Goorhuis; Douglas H Esposito; Davidson H Hamer; Martin P Grobusch Journal: Am J Trop Med Hyg Date: 2018-05-10 Impact factor: 2.345
Authors: Nicholas N Pilau; Aristea A Lubar; Aminu I Daneji; Usman M Mera; Abdullahi A Magaji; Elmina A Abiayi; Kira L Chaiboonma; Emmanuel I Busayo; Joseph M Vinetz; Michael A Matthias Journal: Heliyon Date: 2022-05-21
Authors: Cosme Alvarado-Esquivel; Jesus Hernandez-Tinoco; Luis Francisco Sanchez-Anguiano; Agar Ramos-Nevarez; Sandra Margarita Cerrillo-Soto; Carlos Alberto Guido-Arreola Journal: J Clin Med Res Date: 2015-06-09
Authors: Federico Costa; José E Hagan; Juan Calcagno; Michael Kane; Paul Torgerson; Martha S Martinez-Silveira; Claudia Stein; Bernadette Abela-Ridder; Albert I Ko Journal: PLoS Negl Trop Dis Date: 2015-09-17
Authors: Kathryn J Allan; Holly M Biggs; Jo E B Halliday; Rudovick R Kazwala; Venance P Maro; Sarah Cleaveland; John A Crump Journal: PLoS Negl Trop Dis Date: 2015-09-14
Authors: Cosme Alvarado-Esquivel; Luis Francisco Sánchez-Anguiano; Jesús Hernández-Tinoco Journal: Biomed Res Int Date: 2015-07-09 Impact factor: 3.411